COVID-19 information for patients and families

To help protect our people, patients and communities, we are screening everyone who enters our main hospital buildings. Some of our entrances may be closed or have reduced access.

Please check our COVID-19 information page for more updates before coming to our sites.


Text size: a a a

Laboratory Medicine

Test catalogue

Ethosuximide (Zarontin, Anti-Epileptic, Anti-convulsant)

Test Name

Ethosuximide (Zarontin, Anti-Epileptic, Anti-convulsant)

Red Tube Specimen Type / Requirements

Container Type = 1 Red Top

Minimum Volume = 2 ml serum

Tube must fill to at least ½ or greater of its vacuum capacity

Specimen Handling

Collection Instructions: Collect sample in red top tube without gel separator. Submit trough specimen.Collected within 1 hour prior to next dose or at least 12 hours after last dose. Write your initials, date and time of collection on the collection label.

Laboratory Staff Instructions: Separate from cells within as soon as possible. Avoid gel-separator tubes. Submit two 1 mL aliquots. Store and send frozen

Rejection Criteria: Plasma, gel-separator, Gross hemolysis, Unlabeled or Not Sufficient Quantity Samples will be rejected.

Transportation: Send sample to core lab as soon as possible.

Required Documentation

Turnaround Time (TAT)

5 Days

Test Utilization

Routine

Reference Value

Therapeutic: 280 - 710 µmol/L

Test Code

MISCS

Methodology

HPLC

Testing Location

Referred Out – ON, Canada (ROICL02)

Other Information